在转录组和单细胞测序的背景下,免疫微环境和三阴性乳腺癌的预后基因
Xiangqin Huang1,2,3, Wei Chen1,2,3, Zhiwu Lin1,2,3
1Department of Breast Surgery, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
Scientific reports
|August 12, 2025
概括
这项研究确定了新型免疫相关基因 (IRG) 作为三阴性乳腺癌 (TNBC) 的预后标志物. 这些发现为TNBC治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 免疫相关基因 (IRG) 在三阴性乳腺癌 (TNBC) 的瘤微环境中至关重要.
- 识别可靠的预后标志物对于改善TNBC患者的治疗结果至关重要.
研究的目的:
- 用免疫相关基因发现TNBC的新型预后标志物.
- 开发和验证TNBC预后的预测模型.
主要方法:
- 使用了差异基因表达分析和单变Cox回归.
- 机器学习算法,包括随机生存森林 (RSF),被用于模型开发.
- 构建了一个预后名录图来评估诊断性能.
主要成果:
- 他们发现了六种潜在的预后基因 (BPI,GPHA2,KIR3DL3,MASP1,RASGRP1,SEMA4A).
- 一个RSF模型和预后名ogram被开发和验证.
- 发现RASGRP1主要影响上皮细胞,纤维细胞和T细胞.
结论:
- 已识别的IRG可以作为TNBC的潜在预后生物标志物.
- 该研究提供了对免疫微环境和TNBC治疗潜在药物点的见解.
相关概念视频
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K


